Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. Asia Pacific Tissue Banking Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Tissue Banking Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Tissue Banking Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Tissue Banking Market 36
Figure 12. Breakdown of Asia Pacific Tissue Banking Market by Offering, 2019-2030, % of Revenue 41
Figure 13. Asia Pacific Addressable Market Cap in 2021-2030 by Offering, Value ($ mn) and Share (%) 41
Figure 14. Asia Pacific Tissue Banking Market: Equipment, 2019-2030, $ mn 42
Figure 15. Asia Pacific Tissue Banking Market: Cryopreservation Equipment, 2019-2030, $ mn 44
Figure 16. Asia Pacific Tissue Banking Market: Thawing Equipment, 2019-2030, $ mn 45
Figure 17. Asia Pacific Tissue Banking Market: Quality Control Equipment, 2019-2030, $ mn 46
Figure 18. Asia Pacific Tissue Banking Market: Labeling and Coding Equipment, 2019-2030, $ mn 47
Figure 19. Asia Pacific Tissue Banking Market: Alarming and Monitoring Systems, 2019-2030, $ mn 48
Figure 20. Asia Pacific Tissue Banking Market: Other Equipment, 2019-2030, $ mn 49
Figure 21. Asia Pacific Tissue Banking Market: Accessories and Consumables, 2019-2030, $ mn 50
Figure 22. Asia Pacific Tissue Banking Market: Services, 2019-2030, $ mn 51
Figure 23. Asia Pacific Tissue Banking Market: Screening, 2019-2030, $ mn 53
Figure 24. Asia Pacific Tissue Banking Market: Processing, 2019-2030, $ mn 54
Figure 25. Asia Pacific Tissue Banking Market: Tissue Retrieval, 2019-2030, $ mn 55
Figure 26. Asia Pacific Tissue Banking Market: Testing, 2019-2030, $ mn 56
Figure 27. Asia Pacific Tissue Banking Market: Storage and Preservation, 2019-2030, $ mn 57
Figure 28. Asia Pacific Tissue Banking Market: Other Services, 2019-2030, $ mn 58
Figure 29. Breakdown of Asia Pacific Tissue Banking Market by Application, 2019-2030, % of Sales Revenue 60
Figure 30. Asia Pacific Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 60
Figure 31. Asia Pacific Tissue Banking Market: Therapeutics, 2019-2030, $ mn 61
Figure 32. Asia Pacific Tissue Banking Market: Medical Research, 2019-2030, $ mn 62
Figure 33. Asia Pacific Tissue Banking Market: Cosmetics, 2019-2030, $ mn 63
Figure 34. Asia Pacific Tissue Banking Market: Other Applications, 2019-2030, $ mn 64
Figure 35. Breakdown of Asia Pacific Tissue Banking Market by Tissue Type, 2019-2030, % of Sales Revenue 66
Figure 36. Asia Pacific Addressable Market Cap in 2021-2030 by Tissue Type, Value ($ mn) and Share (%) 66
Figure 37. Asia Pacific Tissue Banking Market: Cardiovascular Tissue, 2019-2030, $ mn 67
Figure 38. Asia Pacific Tissue Banking Market: Corneal Tissue, 2019-2030, $ mn 68
Figure 39. Asia Pacific Tissue Banking Market: Lungs Tissue, 2019-2030, $ mn 69
Figure 40. Asia Pacific Tissue Banking Market: Kidney Tissue, 2019-2030, $ mn 70
Figure 41. Asia Pacific Tissue Banking Market: Bone Tissue, 2019-2030, $ mn 71
Figure 42. Asia Pacific Tissue Banking Market: Skin Tissue, 2019-2030, $ mn 72
Figure 43. Asia Pacific Tissue Banking Market: Brain & Spinal Cord, 2019-2030, $ mn 73
Figure 44. Asia Pacific Tissue Banking Market: Others Tissue Types, 2019-2030, $ mn 74
Figure 45. Breakdown of Asia Pacific Tissue Banking Market by End User, 2019-2030, % of Revenue 76
Figure 46. Asia Pacific Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 76
Figure 47. Asia Pacific Tissue Banking Market: Biobanks, 2019-2030, $ mn 77
Figure 48. Asia Pacific Tissue Banking Market: Hospitals and Clinics, 2019-2030, $ mn 78
Figure 49. Asia Pacific Tissue Banking Market: Research and Academic Institutes, 2019-2030, $ mn 79
Figure 50. Asia Pacific Tissue Banking Market: Other End Users, 2019-2030, $ mn 80
Figure 51. Breakdown of APAC Tissue Banking Market by Country, 2019 and 2030F, % of Revenue 82
Figure 52. Contribution to APAC 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 83
Figure 53. Tissue Banking Market in Japan, 2019-2030, $ mn 85
Figure 54. Tissue Banking Market in China, 2019-2030, $ mn 87
Figure 55. Tissue Banking Market in Australia, 2019-2030, $ mn 89
Figure 56. Tissue Banking Market in India, 2019-2030, $ mn 92
Figure 57. Tissue Banking Market in South Korea, 2019-2030, $ mn 94
Figure 58. Tissue Banking Market in Rest of APAC, 2019-2030, $ mn 96
Figure 59. Growth Stage of Asia Pacific Tissue Banking Industry over the Forecast Period 98
Asia Pacific tissue banking market will grow by 9.6% annually with a total addressable market cap of $85.41 billion over 2021-2030 owing to the increasing demand for regenerative medicines and advancements in tissue preservation and in-house sample testing, an increasing number of biobanks across the globe, and the advancements in the medical drug discovery and biopharmaceuticals industry. Highlighted with 31 tables and 59 figures, this 118-page report “Asia Pacific Tissue Banking Market 2020-2030 by Offering (Equipment, Accessories & Consumables, Services), Application (Therapeutics, Medical Research, Cosmetics), Tissue Type (Cardiovascular, Corneal, Lung, Kidney, Bone, Skin), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific tissue banking market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific tissue banking market in every aspect of the classification from perspectives of Offering, Application, Tissue Type, End User, and Country. Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Equipment o Cryopreservation Equipment o Thawing Equipment o Quality Control Equipment o Labeling and Coding Equipment o Alarming and Monitoring Systems o Other Equipment • Accessories and Consumables • Services o Screening o Processing o Tissue Retrieval o Testing o Storage and Preservation o Other Services Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Therapeutics • Medical Research • Cosmetics • Other Applications Based on Tissue Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Cardiovascular Tissue • Corneal Tissue • Lungs Tissue • Kidney Tissue • Bone Tissue • Skin Tissue • Brain & Spinal Cord • Others Tissue Types Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Biobanks • Hospitals and Clinics • Research and Academic Institutes • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Offering, Application, and Tissue Type over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): AMS Biotechnology Ltd. Avantor Inc. (VWR International) Beckman Coulter, Inc. Bio-Rad Laboratories Inc. Bluechiip Limited Brooks Lifesciences (Brooks Automation Inc.) Custom Biogenic Systems, Inc. Eppendorf AG Hamilton Company Merck KGaA Organ Recovery Systems, Inc. PHC Holdings Corporation Sartorius AG Taylor-Wharton International LLC Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More